Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
JAMA Ophthalmology|December 28, 2018
Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 StudyMichael S Ip, Neal L Oden, Ingrid U Scott, et al.JAMA Ophthalmology|October 28, 2021
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical TrialAhmad A Aref, Ingrid U Scott, Paul C VanVeldhuisen, et al.Ophthalmology|November 20, 2016
SCORE2 Report 2: Study Design and Baseline CharacteristicsIngrid U Scott, Paul C VanVeldhuisen, Michael S Ip, et al.JAMA Ophthalmology|May 11, 2023
Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 TrialSteven M Kymes, Neal L Oden, Paul C VanVeldhuisen, et al.Ophthalmology|March 29, 2011
SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusionClement K Chan, Michael S Ip, Paul C Vanveldhuisen, et al.Ophthalmology|July 22, 2009
SCORE Study report 3: study design and baseline characteristicsMichael S Ip, Neal L Oden, Ingrid U Scott, et al.Journal of Molecular Biology|October 7, 1994
Crystallization and preliminary X-ray diffraction analysis of the ArsC protein from the Escherichia coli arsenical resistance plasmid, R773V S de Mel, M A Doyle, T B Gladysheva, et al.American Journal of Ophthalmology|August 24, 2020
SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical TrialsAndrew Hendrick, Paul C VanVeldhuisen, Ingrid U Scott, et al.JAMA Ophthalmology|June 7, 2019
Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical TrialIngrid U Scott, Paul C VanVeldhuisen, Franca Barton, et al.Ophthalmology. Retina|July 29, 2021
Cluster Analysis and Genotype-Phenotype Assessment of Geographic Atrophy in Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 25Tiarnan D L Keenan, Neal L Oden, Elvira Agrón, et al.Pageof 9